David L. Steed
Chief Tech/Sci/R&D Officer at Noveome Biotherapeutics, Inc.
Profile
David L.
Steed is currently the Chief Medical Officer & VP-Medical Affairs at Noveome Biotherapeutics, Inc. He previously worked as a Surgery Professor at the University of Pittsburgh and served as the President of The Wound Healing Society.
David L. Steed active positions
| Companies | Position | Start |
|---|---|---|
Noveome Biotherapeutics, Inc.
 Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | Chief Tech/Sci/R&D Officer | - |
Former positions of David L. Steed
| Companies | Position | End |
|---|---|---|
| The Wound Healing Society | President | - |
| University of Pittsburgh | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | Health Technology |
| The Wound Healing Society |
- Stock Market
- Insiders
- David L. Steed